Literature DB >> 11085950

Prosaposin: promoter analysis and central-nervous-system-preferential elements for expression in vivo.

Y Sun1, P Jin, D P Witte, G A Grabowski.   

Abstract

The expression of prosaposin is temporally and spatially regulated at the transcriptional and post-translational levels. In vitro, the mouse prosaposin promoter contains functional RORE [retinoic acid-receptor-related orphan receptor alpha subunit (RORalpha)-binding element], Sp1 and U (unknown) sites within 310 bp directly 5' to the transcription start site and additional elements within 2400 bp 5' to the transcription start site. To elucidate promoter regions important to tissue-preferential expression in vivo, transgenic mice were created with 5'-flanking deletions of the prosaposin gene fused to a luciferase reporter. Nearly exclusive expression was observed in cerebrum, cerebellum and eyes of adult transgenic mice containing constructs with 234-310 bp of 5'-flanking DNA. This central nervous system (CNS) expression was due to the presence of RORE and overlapping Sp1 sites in this region. Internal deletion of RORE and the Sp1 cluster from the longer constructs with 2400 bp of 5'-flanking DNA significantly diminished expression in the CNS. The appearance of substantial visceral tissue (e.g. liver, spleen, lung, kidney, thymus and heart) expression was obtained with transgenic mice bearing constructs with 742-2400 bp of 5'-flanking DNA. The cellular localization of luciferase reporter-gene expression from these constructs corresponded closely with that for prosaposin. These results define important CNS and visceral regulatory regions in the promoter in vivo and may be sufficient to account for the majority of prosaposin's tissue-preferential expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085950      PMCID: PMC1221488     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Conformational and amino acid residue requirements for the saposin C neuritogenic effect.

Authors:  X Qi; K Kondoh; D Krusling; G J Kelso; T Leonova; G A Grabowski
Journal:  Biochemistry       Date:  1999-05-11       Impact factor: 3.162

2.  Sulfatide activator protein. Alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease.

Authors:  H Holtschmidt; K Sandhoff; H Y Kwon; K Harzer; T Nakano; K Suzuki
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

3.  The organization of the gene for the human cerebroside sulfate activator protein.

Authors:  H Holtschmidt; K Sandhoff; W Fürst; H Y Kwon; D Schnabel; K Suzuki
Journal:  FEBS Lett       Date:  1991-03-25       Impact factor: 4.124

4.  Insertion in the mRNA of a metachromatic leukodystrophy patient with sphingolipid activator protein-1 deficiency.

Authors:  X L Zhang; M A Rafi; G DeGala; D A Wenger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease.

Authors:  D Schnabel; M Schröder; K Sandhoff
Journal:  FEBS Lett       Date:  1991-06-17       Impact factor: 4.124

6.  Biosynthesis and molecular cloning of sulfated glycoprotein 1 secreted by rat Sertoli cells: sequence similarity with the 70-kilodalton precursor to sulfatide/GM1 activator.

Authors:  M W Collard; S R Sylvester; J K Tsuruta; M D Griswold
Journal:  Biochemistry       Date:  1988-06-14       Impact factor: 3.162

7.  Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases.

Authors:  B D Chang; K Watanabe; E V Broude; J Fang; J C Poole; T V Kalinichenko; I B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

8.  Molecular cloning of a human co-beta-glucosidase cDNA: evidence that four sphingolipid hydrolase activator proteins are encoded by single genes in humans and rats.

Authors:  E G Rorman; G A Grabowski
Journal:  Genomics       Date:  1989-10       Impact factor: 5.736

Review 9.  Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses.

Authors:  K Harzer; B C Paton; A Poulos; B Kustermann-Kuhn; W Roggendorf; T Grisar; M Popp
Journal:  Eur J Pediatr       Date:  1989-10       Impact factor: 3.183

10.  Immunocytochemical localization of sulfated glycoprotein-1 (SGP-1) and identification of its transcripts in epithelial cells of the extratesticular duct system of the rat.

Authors:  L Hermo; C Morales; R Oko
Journal:  Anat Rec       Date:  1992-03
View more
  3 in total

1.  Analyses of temporal regulatory elements of the prosaposin gene in transgenic mice.

Authors:  Ying Sun; David P Witte; Peng Jin; Gregory A Grabowski
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

2.  High Throughput Proteomic Exploration of Hypothermic Preservation Reveals Active Processes within the Cell Associated with Cold Ischemia Kinetic.

Authors:  Ophélie Pasini-Chabot; Julia Vincent; Sylvain Le Pape; Maryne Lepoittevin; Wassim Kaaki; Jean-Baptiste Woillard; Sebastien Giraud; Nicolas Bourmeyster; Thierry Hauet; Raphael Thuillier
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

3.  Regional expression of prosaposin in the wild-type and saposin D-deficient mouse brain detected by an anti-mouse prosaposin-specific antibody.

Authors:  Azusa Yoneshige; Kunihiko Suzuki; Naoya Kojima; Junko Matsuda
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2009       Impact factor: 3.493

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.